Michael Beck
Michael Beck
Clinic of Nuclear Medicine, University Erlangen-Nuremberg
Bestätigte E-Mail-Adresse bei uk-erlangen.de
Titel
Zitiert von
Zitiert von
Jahr
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT
M Wiesmüller, HH Quick, B Navalpakkam, MM Lell, M Uder, P Ritt, ...
European journal of nuclear medicine and molecular imaging 40 (1), 12-21, 2013
1232013
Longitudinal analysis of bone metabolism using SPECT/CT and 99mTc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysis
M Beck, JC Sanders, P Ritt, J Reinfelder, T Kuwert
EJNMMI research 6 (1), 60, 2016
412016
68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
C Schmidkonz, M Cordes, D Schmidt, T Bäuerle, TI Goetz, M Beck, ...
European Journal of Nuclear Medicine and Molecular Imaging 45 (11), 1862-1872, 2018
342018
99mTc‐MIP‐1404‐SPECT/CT for the detection of PSMA‐positive lesions in 225 patients with biochemical recurrence of prostate cancer
C Schmidkonz, C Hollweg, M Beck, J Reinfelder, TI Goetz, JC Sanders, ...
The Prostate 78 (1), 54-63, 2018
332018
First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer
J Reinfelder, T Kuwert, M Beck, JC Sanders, P Ritt, C Schmidkonz, ...
Clinical Nuclear Medicine 42 (1), 26-33, 2017
282017
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ...
Clinical nuclear medicine 43 (4), 225-231, 2018
182018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer
C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ...
Clinical nuclear medicine 43 (8), e250-e258, 2018
92018
Multimodal imaging of bone metastases: From preclinical to clinical applications
S Ellmann, M Beck, T Kuwert, M Uder, T Bäuerle
Journal of Orthopaedic Translation 3 (4), 166-177, 2015
92015
Positron emission tomography–computed tomography versus positron emission tomography–magnetic resonance imaging for diagnosis of oral squamous cell carcinoma: A pilot study
T Schlittenbauer, M Zeilinger, E Nkenke, S Kreißel, MC Wurm, M Lell, ...
Journal of Cranio-Maxillofacial Surgery 43 (10), 2129-2135, 2015
72015
Using Power Watersheds to Segment Benign Thyroid Nodules in Ultrasound Image Data
E Kollorz, E Angelopoulou, M Beck, D Schmidt, T Kuwert
Bildverarbeitung für die Medizin 2011, 124-128, 2011
62011
Tc-99-MIP-1404 Imaging for the Detection of PSMA-Positive Lesions. A Pilot Study in 380 Patients with Histologically Confirmed Prostate Cancer
C Schmidkonz, P Ritt, C Hollweg, M Beck, T Goetz, J Sanders, ...
EANM'17, 2017
22017
Individual Calculation of Effective Dose and Risk of Malignancy Based on Monte Carlo Simulations after Whole Body Computed Tomography
M Kopp, T Loewe, W Wuest, M Brand, M Wetzl, W Nitsch, D Schmidt, ...
Scientific Reports 10 (1), 1-12, 2020
12020
99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of …
C Schmidkonz, A Atzinger, TI Goetz, M Beck, P Ritt, O Prante, T Kuwert, ...
Clinical Nuclear Medicine 45 (2), 105-112, 2020
12020
Repeating of local therapy of distant metastases increases overall survival in patients with synchronous metastasized rectal cancer—a monocentric analysis
M Haderlein, S Lettmaier, M Langheinrich, A Schmid, S Semrau, M Hecht, ...
International Journal of Colorectal Disease 33 (11), 1533-1541, 2018
12018
Diagnosis of Bisphosphonate-Induced Osteonecrosis of the Jaw using the Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions
M Beck, P Ritt, J Sanders, T Kuwert
Journal of Nuclear Medicine 58 (supplement 1), 1217-1217, 2017
12017
First experience with PSMA-SPECT/CT using a 99mTc-labeled PSMA inhibitor for patients with biochemical recurrence of prostate cancer
J Reinfelder, T Kuwert, O Prante, B Wullich, P Hennig, M Beck, J Sanders, ...
Journal of Nuclear Medicine 56 (supplement 3), 67-67, 2015
12015
Effect of Reconstruction Settings on PET-Derived Dose-Volume-Histograms after SIRT of the Liver
RÃ Marc, GÃ Theresa, C Schmidkonz, M Beck, T Kuwert, P Ritt
Journal of Nuclear Medicine 61 (supplement 1), 448-448, 2020
2020
Fünf Jahresverlauf bei Patienten mit jodspeichernden Lymphknotenmetastasen im SPECT/CT belegt den Erfolg der Radiojodtherapie
D Schmidt, M Beck, C Schmidkonz, T Kuwert
Nuklearmedizin 59 (02), V70, 2020
2020
Tc-99m-MIP-1404-SPECT/CT for Patients with Metastatic Prostate Cancer: Inter-and Intraobserver Variability in Treatment-related Longitudinal Tracer Uptake Assessments of PSMA …
A Atzinger, C Schmidkonz, TI Götz, M Beck, P Ritt, O Prante, T Kuwert, ...
Nuklearmedizin 59 (02), P28, 2020
2020
Effect of Reconstruction Settings on PET-Derived Dose-Volume-Histograms after SIRT of the Liver
M Röschlein, TI Götz, C Schmidkonz, M Beck, T Kuwert, P Ritt
Nuklearmedizin 59 (02), P17, 2020
2020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20